Exchange: NASDAQ·Updated 07:30 PM EST

TMCI News

News
all
press releases
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Stock Has Average Price Target of $6.17 According to Analysts
Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) have earned an average rating of "Hold" from the five research firms that are currently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, one has issued a hold recom...
MarketBeat
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Stock Has Average Price Target of $6.17 According to Analysts
Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) have earned an average rating of "Hold" from the five research firms that are currently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, one has issued a hold recom...
MarketBeat
More News
Treace Medical Concepts (TMCI) delivered earnings and revenue surprises of +26.92% and +1.18%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Tandem Diabetes Care (TNDM) delivered earnings and revenue surprises of +62.96% and +6.94%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
UFP (UFPT) delivered earnings and revenue surprises of +9.51% and +3.45%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Alphatec (ATEC) delivered earnings and revenue surprises of -18.18% and -1.38%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Did Treace Medical Concepts, Inc. Insiders Breach their Fiduciary Duties to Shareholders? Did Treace Medical Concepts, Inc. Insiders Breach their Fiduciary Duties to Shareholders?PR NewswireNEW YORK, Sept. 26, 2026 Shareholders are encouraged to contact the firm to discuss their rights and options...
PR Newswire
Tandem Diabetes Care (TNDM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Zacks
Treace Medical Concepts (TMCI) delivered earnings and revenue surprises of +20.00% and +3.42%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Artivion (AORT) delivered earnings and revenue surprises of 0.00% and +4.02%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Did Treace Medical Concepts, Inc. Insiders Breach their Fiduciary Duties to Shareholders? Did Treace Medical Concepts, Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, July 24, 2026 Shareholders are encouraged to contact the firm to discuss their rights and options...
PR Newswire

Advertisement|Remove ads.